Analysts Revise Marsh (MRSH) Price Targets Ahead Of Q3 Earnings
What happened
Wall Street analysts updated their forecasts and price targets for Marsh & McLennan ahead of the company's third-quarter earnings report, according to Benzinga. The revisions came as the insurance broker prepares to release quarterly results in the coming days. The source tagged the item with neutral sentiment.
The QL Read
The QuantLogix composite sits at 44/100 (Neutral) with the stock at $170.06, down 1.04% today. In a tape where financials lag (XLF +0.06% vs. S&P 500 +0.73%) and VIX rises 6.21% to 16.26, the engine's flat read defers direction to the Q3 print.
Not financial advice. QuantLogix is a research platform; nothing in this brief constitutes a recommendation to buy or sell any security. We summarize public news with attribution to the original publisher; visit the source above for the full original article.